Literature DB >> 8172699

Ear disease in children with cystic fibrosis.

J Haddad1, C Gonzalez, G Kurland, D M Orenstein, M L Casselbrant.   

Abstract

OBJECTIVE: To assess otitis media in children with cystic fibrosis.
DESIGN: Prospective prevalence survey.
SETTING: Otolaryngology and cystic fibrosis/pulmonology outpatient clinics, Children's Hospital of Pittsburgh (Pa), a regional referral center. PATIENTS: Seventy patients, aged 4 months to 17 years, with documented cystic fibrosis who presented to the cystic fibrosis/pulmonary clinic with scheduled appointments were asked to volunteer for the study. The 70 patients recruited represent approximately one fourth of the children younger than 17 years with cystic fibrosis who were followed up by the cystic fibrosis/pulmonary clinic. INTERVENTION: Ear, nose, and throat examination including pneumatic otoscopy, with tympanometry when indicated; relevant history taking. MAIN OUTCOME MEASURE: Presence or absence of otitis media.
RESULTS: Seven (10%) of the 70 patients had unilateral or bilateral otitis media.
CONCLUSIONS: Children with cystic fibrosis have a low prevalence of otitis media compared with normal children.

Entities:  

Mesh:

Year:  1994        PMID: 8172699     DOI: 10.1001/archotol.1994.01880290009002

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Changes in the inner ear structures in cystic fibrosis patients.

Authors:  Henrique F Pauna; Rafael C Monsanto; Natsuko Kurata; Michael M Paparella; Sebahattin Cureoglu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-11-16       Impact factor: 1.675

2.  Does amikacin treatment cause subclinical hearing loss in patients with cystic fibrosis?

Authors:  Fevzi Solmaz; Ercan Gündoğdu; Davut Akduman; Mehmet Haksever; Oğuzhan Dikici; Fatih Ünal
Journal:  Toxicol Rep       Date:  2016-03-22

3.  Otitis media prone children with cystic fibrosis: A new normal.

Authors:  Jennifer L McCoy; Thomas M Kaffenberger; Tiffany S Yang; Joseph E Dohar
Journal:  Am J Otolaryngol       Date:  2021-06-19       Impact factor: 2.873

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.